However, it is surprising to see that there was no further benefit in the 4T1 metastatic tumors since the VNTANST targeting should have increased the intratumoral level of PF4, yet thettPF4 did not reduce vessel density in the primary tumors (Supplementary Figure 3). Here, PF4 is linked to metastatic neoplasm.